Search for Clinical Trial Results

Asthma, Aspirin-Induced - 9 Studies Found

Status Study
Not yet recruiting Study Name: Role of Inflammatory Mediators in AERD
Condition: Asthma, Aspirin-Induced
Date: 2016-06-24
Interventions: Drug: aspirin
Completed Study Name: The Effect of Aspirin Desensitization on Patients With Aspirin-exacerbated Respiratory Diseases
Condition: Asthma, Aspirin-Induced
Date: 2013-05-29
Interventions: Drug: aspirin
Not yet recruiting Study Name: Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD)
Condition: Asthma, Aspirin-Induced
Date: 2017-01-19
Interventions:
  • Drug: Ifetroban Oral Capsule S
Active, not recruiting Study Name: Diagnosis of Aspirin Hypersensitivity in Aspirin Exacerbated Respiratory Disease
Condition: Asthma, Aspirin-induced
Date: 2011-03-17
Active, not recruiting Study Name: Therapeutic Control of Aspirin-Exacerbated Respiratory Disease (Aspirin)
Condition:
  • Asthma, Aspirin-Induced
  • Aspirin Exacerbated Asthma

Date: 2012-04-30
Interventions: Drug: Prasugrel Participants will take a 60 mg loading dose. After they will take 10 mg by mouth daily i
Active, not recruiting Study Name: Challenge Test for Acetylsalicylic Acid Hypersensitivity
Condition:
  • Asthma Aspirin-sensitive
  • ASA Intolerant Asthma
  • Date: 2012-08-09
    Interventions:
    • Drug: Acetylsalicylate 1-2 dro
Recruiting Study Name: High Omega-3/Low Omega-6 Treatment Diet for Aspirin-exacerbated Respiratory Disease (AERD)
Condition:
  • ASA Triad
  • Asthma, Nasal Polyps, And Aspirin Intolerance

Date: 2014-02-14
Interventions: Behavioral: Restricting daily intake of omega-6 fatty acids to less than 4 grams and increasing omega-3 fatty acids to 3 grams
Completed Study Name: Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease
Condition: Aspirin Exacerbated Respiratory Disease (AERD)
Date: 2014-08-12
Interventions:
  • Drug: Ifetroban, Oral Capsule
  • Drug: Placeb
COMPLETED Study Name: Aggravated Airway Inflammation: Research on Biological Treatment (Mepolizumab)
Condition: Asthma, Aspirin-Induced
Date: 2026-05-17
Interventions: Solution.Subcutaneous.Mepolizumab is a biological drug, a humanized monoclonal antibody against interleukin-5.